Purdue Pharma to Forfeit $225M in Opioid Settlement as Pfizer Exec Andrew Baum Departs
Purdue Pharma faces a $225 million forfeiture in an opioid settlement, while Pfizer’s chief strategy officer Andrew Baum exits after just months in th...
Purdue Pharma faces a $225 million forfeiture in an opioid settlement, while Pfizer’s chief strategy officer Andrew Baum exits after just months in th...
A federal judge is set to sentence Purdue Pharma to forfeit $225 million on May 14, 2024, finalizing a landmark opioid settlement. The Sackler family...